ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association.

[1]  A. Morales,et al.  Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunction , 1998, International Journal of Impotence Research.

[2]  Tom F. Lue,et al.  Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. , 1998, New England Journal of Medicine.

[3]  A. M. Naylor.  Endogenous neurotransmitters mediating penile erection. , 1998, British journal of urology.

[4]  E. Degerman,et al.  Structure, Localization, and Regulation of cGMP-inhibited Phosphodiesterase (PDE3)* , 1997, The Journal of Biological Chemistry.

[5]  Richard P. Lewis,et al.  ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[6]  J C Gingell,et al.  Sildenafil, a novel effective oral therapy for male erectile dysfunction. , 1996, British journal of urology.

[7]  J. Muller,et al.  Triggering Myocardial Infarction by Sexual Activity: Low Absolute Risk and Prevention by Regular Physical Exertion , 1996 .

[8]  F. Murad,et al.  Nitric Oxide and Cyclic GMP Signaling , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[9]  E. Fisman,et al.  Myocardial ischemia during sexual activity in patients with coronary artery disease. , 1995, The American journal of cardiology.

[10]  G. Hindricks,et al.  Polycystic disease of the kidneys complicating the diagnosis of myocardial echinococcosis. , 1993, European heart journal.

[11]  L. Ignarro,et al.  Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission , 1992 .

[12]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[13]  F. B. Scott,et al.  Evaluation of erectile impotence. , 1988, Urology.

[14]  E. Saltiel,et al.  Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. , 1987, Drugs.

[15]  R. Patterson,et al.  Heart rate, rate-pressure product, and oxygen uptake during four sexual activities. , 1984, Archives of internal medicine.

[16]  G. Fletcher,et al.  Dynamic electrocardiographic recording during sexual activity in recent post-myocardial infarction and revascularization patients. , 1979, American heart journal.